semaglutide .25 mg Wegovy Pill: First Oral GLP-1 for Weight Loss (2025) The Wegovy Pill Is Here:

Novo Nordisk has taken legal action against businesses selling compounded semaglutide that contains impurities, incorrect concentrations, or no semaglutide at all

placebo Average weight loss: 14.9% over 68 weeks (vs

Large-scale clinical trials have demonstrated that GLP-1RAs predominantly exhibit neutral or suppressive effects on overall cancer risk, with semaglutide showing no elevated cancer incidence [14], while significant reductions have been observed in specific malignancies, particularly liver cancers and prostate cancers [13, 15]

How Will My Progress Be Monitored Ongoing monitoring is a key part of responsible obesity care

Starting with a low GLP-1 dose and increasing it slowly might help limit digestive side effects

Encounters of gallbladder inflammation in California hospitals surged by 492% during the study period, potentially linked to the slowed digestion caused by long-term semaglutide use